Diversity, Equity and Inclusion - CLICK HERE
WE ARE
OREGON BIO
Oregon Bio is cultivating conversations with sponsors, members and peers about how diversity and innovation can walk hand-in-hand here in our community. We are learning how systemic bias can negatively impact the advancement of scientific knowledge. We believe we can overcome our differences and disparities by enlarging the opportunities available, and that the bioscience and medtech sectors have important roles to play.
BECOME A MEMBER
WEEKLY NEWSLETTER SIGN UP
BIOSCIENCE IN THE NEWS
RT @Sediabio Visit our booth to chat with our co-founders Dr. Ron Mink and Roger Gale Thursday at 10:00-11:00 PST. We’ll be in the public chat answering your questions, hope to see you there! #AIDS2020Virtual
Current growth in bioscience and medtech sectors drives upward demand for industry-vetted BioPro education
(Portland, Ore.) – With hiring and growth happening at dozens of scientific, manufacturing and biotech companies in the Pacific Northwest, the Oregon Bioscience Association has retooled its myriad educational workforce training, classes and workshops to now be offered online live with industry-expert instructors, through its well-known BioPro program. The recently released Biotechnology Innovation Organization/TEConomy 2020 report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting […]An Open Letter from Daniel O’Day, Chairman & CEO, Gilead Sciences
June 29, 2020 In the weeks since we learned of remdesivir’s potential against COVID-19, one topic has attracted more speculation than any other: what price we might set for the medicine. This degree of speculation is understandable. Remdesivir, our investigational treatment, is the first antiviral to have demonstrated patient improvement in clinical trials for COVID-19 and there is no playbook for how to price a new medicine in a pandemic. We are aware of the significant responsibility that […]
